Harpoon Therapeutics News - HARP

Company Name	Stock Ticker Symbol	Market	Type
Harpoon Therapeutics Inc	HARP	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	23.01	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
				23.01

more quote information »

Recent News

Date	Time	Source	Heading
3/11/2024	17:22	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/11/2024	09:55	EDGAR2	Form POS AM - Post-Effective amendments for registration..
3/11/2024	09:46	EDGAR2	Form S-8 POS - Securities to be offered to employees in..
3/11/2024	08:47	EDGAR2	Form 8-K - Current report
3/08/2024	16:04	EDGAR2	Form 8-K - Current report
2/28/2024	07:37	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
2/28/2024	07:34	EDGAR2	Form 8-K - Current report
2/22/2024	08:32	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
2/22/2024	08:31	EDGAR2	Form 8-K - Current report
2/08/2024	07:00	EDGAR2	Form DEFM14A - Definitive proxy statement relating to merger..
2/06/2024	16:15	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
1/29/2024	16:52	EDGAR2	Form PREM14A - Preliminary proxy statements relating to..
1/29/2024	16:28	EDGAR2	Form 8-K - Current report
1/10/2024	15:07	PRNUS	Kuehn Law Encourages AMAM, HARP, AXNX, and CPE Investors to..
1/09/2024	06:12	IHMARKETNEWS	Wall Street Highlights: HPE and Juniper Networks in..
1/08/2024	17:20	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
1/08/2024	17:16	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
1/08/2024	08:04	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
1/08/2024	08:01	EDGAR2	Form 8-K - Current report
1/08/2024	07:30	BW	Merck to Acquire Harpoon Therapeutics, Further Diversifying..
1/05/2024	17:04	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
12/26/2023	07:30	GLOBE	Harpoon Therapeutics Strengthens Leadership Team
12/22/2023	16:06	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
12/20/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
12/19/2023	07:30	GLOBE	Harpoon Therapeutics Abstract for HPN328 Accepted for Rapid..
12/11/2023	20:15	GLOBE	Harpoon Therapeutics Presents HPN217 Phase 1 Clinical Data..
12/08/2023	16:08	EDGAR2	Form S-3 - Registration statement under Securities Act of..
11/28/2023	16:23	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/28/2023	16:14	EDGAR2	Form 8-K - Current report
11/24/2023	14:06	EDGAR2	Form 8-K - Current report
11/24/2023	14:01	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
11/09/2023	16:28	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/2023	16:11	EDGAR2	Form 8-K - Current report
11/09/2023	16:01	GLOBE	Harpoon Therapeutics Reports Third Quarter 2023 Financial..
11/03/2023	16:05	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
11/02/2023	09:15	GLOBE	Harpoon Therapeutics Abstract for HPN217 Accepted for..
10/26/2023	17:00	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
10/23/2023	08:00	EDGAR2	Form 8-K - Current report
10/23/2023	07:17	GLOBE	Harpoon Therapeutics Announces Up to $150 Million Private..
10/21/2023	11:31	GLOBE	Harpoon Therapeutics Announces Updated Interim Tolerability..
10/16/2023	16:05	GLOBE	Harpoon Therapeutics to Host Webcast Reviewing HPN328..
10/09/2023	16:17	GLOBE	Harpoon Therapeutics to Present Interim Tolerability and..
10/02/2023	17:34	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/28/2023	03:00	GLOBE	Harpoon Therapeutics Presents HPN217 Interim Phase 1 Data at..
9/15/2023	07:15	GLOBE	Harpoon Therapeutics Announces First Patients with Small..
9/13/2023	17:12	DJN	Harpoon Shares Drop 7.3% as AbbVie Declines License Option
9/13/2023	16:55	DJN	Harpoon Therapeutics Says AbbVie Declines to Exercise..
9/13/2023	16:15	EDGAR2	Form 8-K - Current report
9/13/2023	16:05	GLOBE	Harpoon Therapeutics Provides an Update on the HPN217..
9/06/2023	07:30	GLOBE	Harpoon Therapeutics Abstract for HPN217 Accepted for Poster..